Livemedia Home
facebook_icon twitter_icon youtube_icon google_plus_icon instagram rss_icon

 Login / Register to Livemedia


A+ | A-
GR | GLOBAL | UK

28/06/2018 Congresses | 19th European Venous Forum Annual Meeting

Congresses | 19th European Venous Forum Annual Meeting  
 

Share

20.399 total
15 live
3.398 video
15.440 photo
Views:
 
Sort by Date | Views
Watch on demand the 19th European Venous Forum Annual Meeting to be held on 28-30 June 2018 in Athens, at the Royal Olympic Hotel.

For the program click here

For more information click here.
28/06 
08:30 - 10:30
Abstract Session 1 

Venous Thromboembolism and Thrombolysis

Evaluated
Evaluation
08:30 - 08:50
1.1 Magnetic resonance multi-sequence thrombus imaging (MSTI) in patients with acute iliofemoral deep vein thrombosis can predict thrombus lysability

Evaluated
Evaluation
08:50 - 09:10
1.2 Catheter-directed thrombolysis versus angiojet pharmacomechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis

Evaluated
Evaluation
09:10 - 09:30
1.3 Use of micronized purified flavonoid fraction in combination with oral rivaroxaban improves clinical and ultrasound outcomes of proximal deep vein thrombosis

Evaluated
Evaluation
09:30 - 09:50
1.4 Comparison of in-patient outcomes and mortality of venous thromboembolismrelated hospitalizations between solid and hematological malignancies: a nationwide inpatient sample database analysis

Evaluated
Evaluation
09:50 - 10:10
1.5 Effect of underwater compression on leg venous diameters and calf volume

Evaluated
Evaluation
10:10 - 10:30
1.6 Long-term follow-up of physical aspects in 53 iliac stents - evaluated by 3D CT - in patients treated with catheter-directed thrombolysis for iliofemoral DVT

Evaluated
Evaluation

Chairmen: Α. Nicolaides, M. Lugli

10:30 - 11:00
Refreshments and visit to Exhibition - Visit Poster Presentations 

11:00 - 12:00
Industry Session 1 

Evaluated
Evaluation
12:00 - 13:20
Abstract Session 2 

Reflux and Varicose Vein Recurrence

Evaluated
Evaluation
12:00 - 12:20
2.1 Characteristics of venous reflux in different body positions: Role of gravity

Evaluated
Evaluation
12:20 - 12:40
2.2 Stationary aggregates at the valve sinus: Markers of venous stasis, predictors of venous insufficiency?

Evaluated
Evaluation
12:40 - 13:00
2.3 Recurrences after varicose vein treatment: anatomical presentation, symptomatology and risk factors

Evaluated
Evaluation
13:00 - 13:20
2.4 CHORUS: Chronic venous and hemorrhoidal diseases evaluation and scientific research results of an international observational survey

Evaluated
Evaluation

Chairmen: M. Vandendriessche, M. Lazarides

13:20 - 14:20
Lunch and visit to Exhibition - e-Poster Presentations 

13:20 - 13:22
eP1 Long-term vein diameter reduction by perivenous hyaluronan instead of tumescence for endovenous procedures

Evaluated
Evaluation
13:22 - 13:24
eP2 Biomatrix sclerofoam: a first step to viscous microfoams

Evaluated
Evaluation
13:24 - 13:26
eP3 Rationale for micronized purified flavonoid fraction administration during sclerotherapy of reticular veins and telangiectasias: results of the national, multicenter, observational program VEIN act prolonged-C1

Evaluated
Evaluation
13:26 - 13:28
eP4 Accessory saphenous vein occlusion after endovenous laser ablation using a radial fiber for great saphenous vein insufficiency

Evaluated
Evaluation
13:28 - 13:30
eP5 Randomized, comparative and prospective study between radiofrequency venous ablation and sclerotherapy with polidocanol foam 3% versus only radiofrequency venous ablation in saphenous veins of 1.5 cm of diameter or more

Evaluated
Evaluation
13:30 - 13:32
eP6 Tumescence saline flush sclerotherapy - another step in evolution

Evaluated
Evaluation
13:32 - 13:34
eP7 An original experimental model of autologous deep venous neovalve formation

Evaluated
Evaluation
13:34 - 13:36
eP8 Surgical treatment of tumor etiology superior vena cava syndrome

Evaluated
Evaluation
13:36 - 13:38
eP9 Hyperpigmentation as an aesthetic feature of early postoperative period following mechanochemical obliteration of veins using the flebogrif system

Evaluated
Evaluation
13:38 - 13:40
eP10 The experience of the treatment of endovenous heat-induced thrombosis after endovenous laser ablation by rivaroxaban

Evaluated
Evaluation
13:40 - 13:42
ep11 Full energy efficiency for segmental ablation of big saphenous veins

Evaluated
Evaluation
13:42 - 13:44
eP12 The effect of fiber tip distance from saphenofemoral junction on outcomes after endovenous thermal ablation

Evaluated
Evaluation
13:44 - 13:46
eP13 Retroperitoneal endoscopic resection of the gonadal veins – A new method of treatment for pelvic congestion syndrome

Evaluated
Evaluation
13:46 - 13:48
eP14 Thermal endovenous therapy is as effective as vein surgery in achieving healing of leg ulcers secondary to superficial vein incompetence

Evaluated
Evaluation
13:48 - 13:50
eP15 Early postoperative period complications after mechano-chemical obliteration of veins using the flebogrif system

Evaluated
Evaluation
13:50 - 13:52
eP16 Varicose vein surgery, does it matter who does it?

Evaluated
Evaluation
13:52 - 13:54
eP17 The burden of depression in patients with chronic venous disease: Results of an epidemiological study from Romania

Evaluated
Evaluation
13:54 - 13:56
eP18 Clinical anatomy of the key perforating veins of the femoral and popliteal regions

Evaluated
Evaluation
13:56 - 13:58
eP19 Vein valve defects and insufficiency in children

Evaluated
Evaluation
13:58 - 14:00
eP20 Long term follow-up of over 500 patients from a single centre, post varicose vein intervention; how much are patients still affected?

Evaluated
Evaluation
14:00 - 14:02
eP21 Anatomical characteristics of the most important perforating veins of the calf, ankle, and foot

Evaluated
Evaluation
14:02 - 14:04
eP22 Laser treatment of recurrent gsv varicosity after classic surgery

Evaluated
Evaluation
14:04 - 14:06
eP23 Endoluminal Occlusion Foam Therapy (ENOF) on great saphenous veins: Occlusion, failure, and other outcomes

Evaluated
Evaluation
13:20 - 14:20
Meet the Experts Session 

Hot Topics on Current Management of Venous Thromboembolism

Evaluated
Evaluation
13:20 - 13:25
DOACs experience with routine use and current shortcomings

Evaluated
Evaluation

Speaker: M. Matsagkas

13:25 - 13:40
Discussion

13:40 - 13:45
Impact of ATTRACT study on the use of pharmaco-mechanical thrombolysis

Evaluated
Evaluation

Speaker: A. Comerota

13:45 - 14:00
Discussion

14:00 - 14:05
Current issues on the management of superficial vein thrombosis

Evaluated
Evaluation

Speaker: A. Giannoukas

14:05 - 14:20
Discussion

Chairmen: A. Mansilha, M. Matsagkas

14:20 - 15:20
Industry Session 2 

Evaluated
Evaluation
15:20 - 16:40
Abstract Session 3 

Varicose Veins

Evaluated
Evaluation
15:20 - 15:40
3.1 Compression stockings in the prevention of venous disorders in pregnancy

Evaluated
Evaluation
15:40 - 16:00
3.2 Efficacy of micronized purified flavonoid fraction on postoperative symptoms after endovenous thermal ablation. A pilot randomized controlled study

Evaluated
Evaluation
16:00 - 16:20
3.3 Management of anterior accessory of the great saphenous vein

Evaluated
Evaluation
16:20 - 16:40
3.4 Surgery versus foam sclerotherapy in patients with isolated anterior accessory saphenous vein varicosis: A randomized clinical study

Evaluated
Evaluation

Chairmen: N. Baekgaard, O. Bottini

16:40 - 17:00
Refreshments and visit to Exhibition - Visit e-Poster Presentations  

17:00 - 18:20
Abstract Session 4 

Miscellaneous

Evaluated
Evaluation
17:00 - 17:20
4.1 Validation of the 3D sym vein symptom assessment tool

Evaluated
Evaluation
17:20 - 17:40
4.2 Effect of treadmill exercise on calf haemodynamics

Evaluated
Evaluation
17:40 - 18:00
4.3 A new risk assessment model better predicts venous thromboembolism risks in Asian surgical patients

Evaluated
Evaluation
18:00 - 18:20
4.4 Presentation patterns and prognosis of 109 isolated venous injuries in 99 patients

Evaluated
Evaluation

Chairmen: E. Rabe, T. Zubilewicz

18:20 - 19:30
Welcome Reception. Exhibition Areas 

29/06 
08:30 - 10:30
Abstract Session 5 

Venous Thromboembolism and Postthrombotic Syndrome

Evaluated
Evaluation
08:30 - 08:50
5.1 Time of anticoagulant treatment initiation and severity of postthrombotic syndrome in patients with deep vein thrombosis: Prospective observational study

Evaluated
Evaluation
08:50 - 09:10
5.2 Determination of a venous thrombus age with a new ultrasound sign

Evaluated
Evaluation
09:10 - 09:30
5.3 Increased risk for recurrent thromboembolic events during the first three months in patients with superficial vein thrombosis treated with tinzaparin

Evaluated
Evaluation
09:30 - 09:50
5.4 Just-in-time: Importance of early duplex surveillance following deep venous stenting for the treatment of post-thrombotic syndrome

Evaluated
Evaluation
09:50 - 10:10
5.5 Early identification of patients with high risk for ilio-femoral DVT

Evaluated
Evaluation
10:10 - 10:30
5.6 Algorithm for preventing severe forms of venous insufficiency from the perspective of the correction of endothelial dysfunction and genetic status

Evaluated
Evaluation

Chairmen: D. Heim, P. Antignani

10:30 - 11:00
Refreshments and visit to Exhibition - Visit e-Poster Presentations  

11:00 - 12:00
Industry Session 3 

Evaluated
Evaluation
12:00 - 12:30
EVF Invited Lecture 

Evaluated
Evaluation
12:00 - 12:30
"Αεί ο Θεός γεωμετρεί" - A quest for God's geometry in venous valve physiology and surgical repair

Evaluated
Evaluation

Speaker: R. Tripathi

Chairmen: A. Giannoukas, K. Ktenidis

12:30 - 13:30
Didactic Session 1: Updates based on results of recent studies 

Evaluated
Evaluation
12:30 - 12:42
Results of EVRA Study

Evaluated
Evaluation

Speaker: A. Davies

12:42 - 12:50
Discussion

12:50 - 13:02
Current status of thrombolysis

Evaluated
Evaluation

Speaker: A. Comerota

13:02 - 13:10
Discussion

13:10 - 13:22
Current Status and indications for intermittent pneumatic compression

Evaluated
Evaluation

Speaker: Α. Nicolaides

13:22 - 13:30
Discussion

Chairmen: M. Perrin, C. Liapis

13:30 - 14:30
Lunch and visit to Exhibition - e-Poster Presentations 

13:30 - 13:32
eP24 The incidence of venous outflow obstruction as a complicating factor of retroperitoneal fibrosis

Evaluated
Evaluation
13:32 - 13:34
eP25 Venous insufficiency treatment and the effect on quality of life

Evaluated
Evaluation
13:34 - 13:36
eP26 Chronic venous disease and hemorrhoids: Is there any association? Results of the Russian part of international program CHORUS

Evaluated
Evaluation
13:36 - 13:38
eP27 A case-control study assessing the calf muscle function by near-infrared spectroscopy in patients with superficial venous insufficiency and deep venous thrombosis

Evaluated
Evaluation
13:38 - 13:40
eP28 Does superficial vein size correlate to advanced disease? Does size matter?

Evaluated
Evaluation
13:40 - 13:42
eP29 Area versus diameter CT measurements for May Thurner Syndrome: Have we been measuring it all wrong

Evaluated
Evaluation
13:42 - 13:44
eP30 Venous circulation disorders: Results of a study conducted on a global representative sample of patients from 8 countries

Evaluated
Evaluation
13:44 - 13:46
eP31 Management of premenstrual transient phlebopathy by intermittent cyclic courses of treatment with micronized purified flavonoid fraction

Evaluated
Evaluation
13:46 - 13:48
eP32 Adherence to nonoperative treatments in outpatients with chronic venous disorders: Results of VEIN act program

Evaluated
Evaluation
13:48 - 13:50
eP33 Venous bed transformation after the elimination of pathological reflux in the great saphenous vein on the level of thigh: 3-year results

Evaluated
Evaluation
13:50 - 13:52
20 years experience with “sourcing-technique” – A simple method to detect reflux routes causing an ulcer by duplex

Evaluated
Evaluation
13:52 - 13:54
eP35 Peripheral neuropathic pain (PNPP) in venous ulcers (VU)

Evaluated
Evaluation
13:54 - 13:56
eP36 Effects of hesperidine methylchalcone and vitamin C and their combination with ruscus extract and of micronized diosmine on ischemia followed by reperfusion

Evaluated
Evaluation
13:56 - 13:58
eP37 Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease

Evaluated
Evaluation
13:58 - 14:00
eP38 Early and intermediate results of surgical treatment of superficial venous thrombosis: Prospective observational controlled study

Evaluated
Evaluation
14:00 - 14:02
eP39 1 h NMR metabolic phenotyping of acute deep vein thrombosis

Evaluated
Evaluation
14:02 - 14:04
eP40 Endovenous treatment of acute iliofemoral vein thrombosis with aspiration thrombectomy catheter – early clinical outcomes

Evaluated
Evaluation
14:04 - 14:06
eP41 Prior history of superficial vein thrombophlebitis as a predictor of recanalization after endovenous laser ablation

Evaluated
Evaluation
14:06 - 14:08
eP42 Diagnosis and surgical treatment of floating thrombosis in inferior vena cava system in concomitant injury

Evaluated
Evaluation
14:08 - 14:10
eP43 Initial experience for the use of therapeutic dose tinzaparin for a short period in the management of lower limb superficial thrombophlebitis and literature review

Evaluated
Evaluation
14:10 - 14:12
eP44 Oral rivaroxaban in the treatment of upper extremity deep vein thrombosis

Evaluated
Evaluation
14:12 - 14:14
eP45 Assessment of D-dimer level as a potential marker for venous thromboembolism in patients with cardiac implantable electronic devices

Evaluated
Evaluation
14:14 - 14:16
eP46 Heparin resistance in surgical patients: could individualized prophylaxis through recognition of high and low responders to antithrombotic treatment represents an option to optimal antithrombotic strategy in the future?

Evaluated
Evaluation

Chairmen: B. Eklof, P. Poredos, M. Malouf, M. Patel

13:30 - 14:15
Meet the Experts Session 

Hot Topics in Chronic Venous Disease

Evaluated
Evaluation
13:30 - 13:35
What you should say to the patients about CVD progression?

Evaluated
Evaluation

Speaker: E. Rabe

13:35 - 13:45
Discussion

13:45 - 13:50
When the saphenous trunks should be spared?

Evaluated
Evaluation

Speaker: N. Labropoulos

13:50 - 14:00
Discussion

14:00 - 14:05
Misconceptions of compression in venous disease

Evaluated
Evaluation

Speaker: N. Labropoulos

14:05 - 14:15
Discussion

Chairmen: E. Shaydakov, D. Milic

14:30 - 15:00
EVF Annual General Meeting  

(Members Only)

Evaluated
Evaluation
15:00 - 16:30
Prize winning papers from the American Venous Forum, American College of Phlebology and the Japanese Society of Phlebology 

Evaluated
Evaluation
15:00 - 15:15
Pr1 Persistently low inferior vena cava retrieval rates in a population-based cohort

Presentation from American Venous Forum (AVF)

Evaluated
Evaluation
15:15 - 15:30
Pr2 Nuclear magnetic resonance spectroscopic analysis of biofluids from patients with chronic venous disease

Presentation from American Venous Forum (AVF)

Evaluated
Evaluation
15:30 - 15:45
Pr3 United States endovenous ablation practice trends: Four year review of medicare provider utilisation and payment

Presentation from American Venous Forum (AVF)

Evaluated
Evaluation
15:45 - 16:00
Pr4 Nutcracker syndrome can be over-diagnosed by duplex ultrasound – left ovarian vein reflux can be the cause of renal vein narrowing rather than an effect of obstructive flow

Presentation from American College of Phlebology (ACP)

Evaluated
Evaluation
16:00 - 16:15
Pr5 Diagnostic efficacy of duplex and near-infrared spectroscopy-derived parameters in predicting post-thrombotic syndrome in patients with a first episode of DVT

Presentation from Japanese Society of Phlebology (JSP)

Evaluated
Evaluation
16:15 - 16:30
Pr6 Comparison of efficacy and safety between DOAC and conventional therapy in patients with intermediate-risk pulmonary embolism

Presentation from Japanese Society of Phlebology (JSP)

Evaluated
Evaluation

Chairmen: A. Comerota, A. Giannoukas

16:30 - 17:00
Refreshments and visit to Exhibition - Visit to e-Poster Presentations  

17:00 - 19:00
Didactic Session 2: Challenging Problems in Chronic Venous Disease 

Joint Session of the European Venous Forum, Balkan Venous Forum and Hellenic Phlebological Society

Evaluated
Evaluation
17:00 - 17:12
Quantitative changes in microcirculation across CEAP C0-C6 classes and the effect of VAD on such changes

Evaluated
Evaluation

Speaker: E. Bouskela

17:12 - 17:20
Discussion

17:20 - 17:32
Can we prevent progression of skin changes in CVD?

Evaluated
Evaluation

Speaker: N. Labropoulos

17:32 - 17:40
Discussion

17:40 - 17:52
Efficacy of venoactive drugs in the management of symptoms and signs of chronic venous disease

Evaluated
Evaluation

Speaker: S. Kakkos

17:52 - 18:00
Discussion

18:00 - 18:12
Current management of patients with C0s disease

Evaluated
Evaluation

Speaker: M. Perrin

18:12 - 18:20
Discussion

18:20 - 18:32
How I select patients for foam sclerotherapy and how I can minimise the associated complications

Evaluated
Evaluation

Speaker: J.J. Guex

18:32 - 18:40
Discussion

18:40 - 18:52
Can we reduce the risk of pigmentation after UGFS or thermal ablation?

Evaluated
Evaluation

Speaker: C. Hamel-Desnos

18:52 - 19:00
Discussion

Chairmen: M. Vuylsteke, M. Kurtoğlu

20:30 - 21:30
Congress Dinner 

Ioannis Rooftop Restaurant, Royal Olympic Hotel

30/06 
08:30 - 10:30
Abstract Session 6 

Miscellaneous

Evaluated
Evaluation
08:30 - 08:50
6.1 Silent pulmonary embolism in patients with symptomatic deep vein thrombosis – an underestimated complication

Evaluated
Evaluation
08:50 - 09:10
6.2 A randomized trial of class 2 and class 3 elastic compression in the prevention of recurrence of venous ulceration

Evaluated
Evaluation
09:10 - 09:30
6.3 Clinical efficacy of a new once-daily 1000 mg oral suspension of micronized purified flavonoid fraction in patients suffering from symptomatic chronic venous disease

Evaluated
Evaluation
09:30 - 09:50
6.4 Utility of an algorithm combining VVSYMQ® and VCSS scores to predict disease severity in C2 patients

Evaluated
Evaluation
09:50 - 10:10
6.5 TRAP (Three-dimensional Restorative Ambulatory Phlebotherapy): A new conservative treatment for chronic vein insufficiency

Evaluated
Evaluation
10:10 - 10:30
6.6 Mini-invasive foam sclerotherapy assisted ligation vs surgical flush ligation for incompetent sapheno-popliteal junction treatment

Evaluated
Evaluation

Chairmen: M. De Maeseneer, I. Tsolakis

10:30 - 11:00
Refreshments and visit to Exhibition - Visit Poster Presentation  

11:00 - 13:00
Didactic Session 3: Challenging Problems in Venous Thromboembolism 

Joint Session of the European Venous Forum, Balkan Venous Forum and Hellenic Phlebological Society

Evaluated
Evaluation
11:00 - 11:12
Towards a new classification of the deep vein thrombosis

Evaluated
Evaluation

Speaker: T. Feodor

11:12 - 11:20
Discussion

11:20 - 11:32
Facts about iliofemoral thrombosis

Evaluated
Evaluation

Speaker: A. Gasparis

11:32 - 11:40
Discussion

11:40 - 11:52
Expanding the treatment options of superficial vein thrombosis with rivaroxaban

Evaluated
Evaluation

Speaker: E. Rabe

11:52 - 12:00
Discussion

12:00 - 12:12
Endophlebectomy of the common femoral vein and endovascular iliac vein recanalization for chronic ilio-femoral venous occlusion

Evaluated
Evaluation

Speaker: M. Dumantepe

12:12 - 12:20
Discussion

12:20 - 12:32
Retroperitoneal venous compression syndromes: A new surgical strategy based on qualitative and quantitative duplex ultrasound examination in the presence of CTA and/or MRI imaging

Evaluated
Evaluation

Speaker: W. Sandmann

12:32 - 12:40
Discussion

12:40 - 12:52
Complications of endovascular treatment of May-Thurner syndrome

Evaluated
Evaluation

Speaker: G. Geroulakos

12:52 - 13:00
Discussion

Chairmen: S. Vasdekis, I. Bihari

13:00 - 13:15
Closing Remarks - Presentation of EVF 2019 - End of Meeting  

Evaluated
Evaluation
13:00 - 13:10
Presentation of EVF 2019

Evaluated
Evaluation

Speaker: D. Heim

13:15 - 14:30
Didactic Session 4: Venous and Lymphatic Diseases Management 

Balkan Venous Forum and Hellenic Phlebological Society

Evaluated
Evaluation
13:15 - 13:30
Surgical treatment of great saphenous thrombosis involving sapheno-femoral junction: a 5-year retrospective study in Albania

Evaluated
Evaluation

Speaker: S. Xhepa

13:30 - 13:45
Lymphedema stage III: What must/ can we do?

Evaluated
Evaluation

Speaker: T. Planinsek-Rucigaj

13:45 - 14:00
Outcomes of the treatment of varicose veins with STEAM

Evaluated
Evaluation

Speaker: I. Droc

14:00 - 14:15
Pregnancy after thrombolysis for ilio-femoral DVT. Outcome and complications, 20 year experience

Evaluated
Evaluation

Speaker: G. Szendro

14:15 - 14:30
Challenging issues in patients receiving DOACs when emergency surgery required

Evaluated
Evaluation

Speaker: E. Arnaoutoglou

Chairmen: A. Papageorgiou, E. Goranova

14:30 - 15:30
Balkan Venous Forum General Assembly 

Evaluated
Evaluation
15:30 - 19:15
VENOUS WORKSHOP: Current updates in Venous diseases treatment 

EUROPEAN VENOUS FORUM, BALKAN VENOUS FORUM, HELLENIC PHLEBOLOGICAL SOCIETY

Evaluated
Evaluation
15:30 - 15:51
Station 1: Tips and tricks on Foam Sclerotherapy

Evaluated
Evaluation

Speaker: J.J. Guex

15:51 - 16:12
Station 2: Endovenous procedures with laser

Evaluated
Evaluation

Speaker: T. Urbanek

16:12 - 16:33
Station 3: Laser treatment for varicose veins

Evaluated
Evaluation

Speaker: C. Karathanos

16:33 - 16:54
Station 4: Mechano-chemical tumescentless endovenous treatment

Evaluated
Evaluation

Speaker: A. Gasparis

16:54 - 17:15
Station 5: Venous stenting - 1

Evaluated
Evaluation

Speaker: G. Geroulakos

17:15 - 17:30
BREAK

Evaluated
Evaluation
17:30 - 17:40
Station 6: Treatment of varicose veins with RF

Evaluated
Evaluation

Speaker: A. Lazaris

17:40 - 18:00
Station 7: Tumescentless endovenous treatment with glue

Evaluated
Evaluation

Speaker: N. Roussas

18:00 - 18:20
Station 8: Venous stenting - 2

Evaluated
Evaluation

Speaker: A. Gasparis

18:20 - 18:40
Station 9: IVC filters

Evaluated
Evaluation

Speaker: D. Tsetis

18:40 - 19:00
Station 10: Intravascular ultrasound in venous interventions

Evaluated
Evaluation

Speaker: R. Kretzschmar

19:10 - 19:30
Station 11: Treatment of varicose veins with laser

Evaluated
Evaluation

Speaker: K. Spanos

19:00 - 19:15
End of Meeting - Adjournment 

Evaluated
Evaluation